Glycomics Companies Market Position Advancements, Value Creation, Cross-border Expansion, Patent Expansions, Financial Performance Evaluation, Risk Mitigation, Licensing and Monetization, Efficiency Metrics

Glycomics Key Players and their Developments

The global glycomics market size is calculated at US$ 2.21 in 2024, grew to US$ 2.53 billion in 2025, and is projected to reach around US$ 8.66 billion by 2034. The market is expanding at a CAGR of 14.64% between 2024 and 2034.

Top Companies in the Glycomics

• Thermo Fisher Scientific, Inc.
• Merck KgaA
• Agilent Technologies Inc.
• Bruker
• New England Biolabs
• Shimadzu Corporation
• Waters Corporation
• Takara Bio Inc
• Asparia Glycomics
• RayBiotech Life, Inc.

Recent Developments in the Glycomics Market

• In October 2024, the privately owned biotechnology business Crescent Biopharma, Inc., which is developing a pipeline of cancer treatments intended to treat solid tumors, has agreed to acquire GlycoMimetics, Inc. The company intends to operate under the name Crescent Biopharma, Inc. when the deal is completed.
• In August 2024, in order to establish the BioFoundry: Glycoscience Resources, Education, And Training (BioFoundry: GREAT), a comprehensive initiative to raise awareness, interest, knowledge, and participation in carbohydrate science, UGA was granted a six-year, $18 million award from the National Science Foundation's BioFoundries program.

U.S. Healthcare Product Shipments: Consignee, Shipper, Quantity and Weight (2023 - 24)